An Observational Study to Evaluate the Safety and Efficacy of Cetuximab in Combination With Platinum-based Chemotherapy in the First-line Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck
Clinical trial NCT01142869 · TERMINATED
Trial details
- NCT number
- NCT01142869
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2009-12-31
- Primary completion
- 2013-07-31
- Enrollment
- 133
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.